Key Insights

Highlights

Success Rate

60% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 85/100

Termination Rate

20.0%

2 terminated out of 10 trials

Success Rate

60.0%

-26.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results60% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (4)

Trial Status

Completed3
Unknown2
Terminated2
Recruiting2
Enrolling By Invitation1

Trial Success Rate

60.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (10)

Research Network

Activity Timeline